Levodopa Market - Size, Share, Outlook, and Analysis by 2018-2026

Levodopa Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2018-2026
REPORT DESCRIPTION
Levodopa Market – Overview
Development of novel formulations and efficient drug delivery methods for levodopa are expected to drive
growth of the levodopa market. For instance, a clinical study for gastric retentive Accordion Pill, an immediate
drug release formulation by Intec Pharma Ltd., is ongoing in clinical phase III and is expected to complete in
September 2018. Accordion Pill is a Carbidopa/Levodopa (AP-CD/LD) combinational oral drug delivery system,
which is designed to improve the efficacy and safety of existing CD/LD drugs by utilizing an efficient gastric
retention and specific release mechanism.
Moreover, Impel NeuroPharma Inc. is conducting phase II clinical study for INP103, a drug-device combination
product containing a drug component, L-dopa, and device component I231 Precision Olfactory Delivery (POD)
device. The study is expected to complete in November 2018.
Furthermore, advancement in diagnosis of Parkinson's disease (PD) progression is expected to boost growth of
levodopa market. For instance, a clinical study conducted by Washington University School of Medicine, for
measuring PD progression both by using Magnetic Resonance Imaging (MRI) and by controlled dose of levodopa
for discovering suitable biomarker of PD is currently in clinical phase I and is expected to complete in February
2019.
REPORT DESCRIPTION
Levodopa Market Taxonomy:
By Application
Parkinson’s Disease
Dopamine Responsive Dystonia
By Drug Type
Rytary
Duopa
Sinemet
Caramet
By Distribution Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Get Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2247
REPORT DESCRIPTION
Levodopa Market – Key Players
Taj Pharmaceuticals Limited
Guangzhou HanFang Pharmaceutical Company Limited
Poulvet.com
Teva Pharmaceutical Industries Ltd
UBM
Zhejiang Wild Wind Pharmaceutical Co
SWAPNROOP
Furthermore, in November 2015, Impax Laboratories, Inc. received European Commission (EC) marketing
authorization for NUMIENT (Levodopa and Carbidopa), a modified-release oral capsule formulation for
the symptomatic treatment of adult patients with Parkinson's disease in Europe region.
Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/levodopa-market-2247
ABOUT COHERENT MARKET INSIGHTS
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its
plethora of clients achieve transformational growth by helping them make critical business decisions. We are
headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players
from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various recommendations about
operational improvements, technologies, emerging market trends and new working methods. We offer both
customized and syndicated market research reports that help our clients create visionary growth plans to
provide traction to their business. We meticulously study emerging trends across various industries at both the
global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE SERVICES
CUSTOMIZED RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS







Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
ABOUT US
KEY STATS
RESEARCH
SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARCH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare,
and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports
across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique
—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our
clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities
posed therein.
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702

Nearly all patients receive the dopamine precursor levodopa, which adequately control symptoms of Parkinson's disease (PD) at early stage of the disease.